Wednesday, March 6, 2019

NPR News: FDA Approves Esketamine Nasal Spray For Hard-To-Treat Depression

FDA Approves Esketamine Nasal Spray For Hard-To-Treat Depression
Three decades after Prozac arrived, consumers are getting a new kind of antidepressant. The medicine is based on the anesthetic ketamine, which has been used illicitly as a party drug.

Read more on NPR

No comments:

Post a Comment